Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph J Shatzel

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
European Journal of Haematology|April 23, 2019
A comparative analysis of the safety profile of direct oral anticoagulants using the FDA adverse event reporting systemEmma P DeLoughery, Joseph J Shatzel
European Journal of Haematology|December 3, 2020
The hematologic consequences of obesityJohanna C Purdy, Joseph J Shatzel
The Medical Clinics of North America|February 13, 2017
Syndromes of Thrombotic MicroangiopathyJoseph J Shatzel, Jason A Taylor
Hematology. American Society of Hematology. Education Program|December 7, 2024
Gender-affirming hormone therapy in the transgender patient: influence on thrombotic riskHannah King, Thalia Padilla Kelley, Joseph J Shatzel
Transfusion|December 13, 2016
Rapid and durable response to intravenous immunoglobulin in delayed heparin-induced thrombocytopenia: a case reportBrandon Z Lei, Joseph J Shatzel, Merav Sendowski
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
Asymptomatic "breakthrough" thrombosis and anticoagulant "failure": Keep calm and carry onSven R Olson, Joseph J Shatzel, Thomas G DeLoughery
JAMA Oncology|December 14, 2018
Cyclin-Dependent Kinase Inhibitor-Associated ThromboembolismSven R Olson, Thomas G DeLoughery, Joseph J Shatzel
American Journal of Hematology|October 26, 2016
Thrombotic issues in transgender medicine: A reviewJoseph J Shatzel, Kara J Connelly, Thomas G DeLoughery
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Cyclin-dependent kinase 4/6 inhibitor-associated thromboembolism: a critical evaluation of the current evidenceNathan W Watson, Joseph J Shatzel, Hanny Al-Samkari
Thrombosis and Haemostasis|April 15, 2016
Non-vitamin K antagonist oral anticoagulants for heparin-induced thrombocytopenia. A systematic review of 54 reported casesJoseph J Shatzel, Meg Crapster-Pregont, Thomas G Deloughery
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
European Journal of Haematology|April 23, 2019
A comparative analysis of the safety profile of direct oral anticoagulants using the FDA adverse event reporting systemEmma P DeLoughery, Joseph J Shatzel
European Journal of Haematology|December 3, 2020
The hematologic consequences of obesityJohanna C Purdy, Joseph J Shatzel
The Medical Clinics of North America|February 13, 2017
Syndromes of Thrombotic MicroangiopathyJoseph J Shatzel, Jason A Taylor
Hematology. American Society of Hematology. Education Program|December 7, 2024
Gender-affirming hormone therapy in the transgender patient: influence on thrombotic riskHannah King, Thalia Padilla Kelley, Joseph J Shatzel
Transfusion|December 13, 2016
Rapid and durable response to intravenous immunoglobulin in delayed heparin-induced thrombocytopenia: a case reportBrandon Z Lei, Joseph J Shatzel, Merav Sendowski
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
Asymptomatic "breakthrough" thrombosis and anticoagulant "failure": Keep calm and carry onSven R Olson, Joseph J Shatzel, Thomas G DeLoughery
JAMA Oncology|December 14, 2018
Cyclin-Dependent Kinase Inhibitor-Associated ThromboembolismSven R Olson, Thomas G DeLoughery, Joseph J Shatzel
American Journal of Hematology|October 26, 2016
Thrombotic issues in transgender medicine: A reviewJoseph J Shatzel, Kara J Connelly, Thomas G DeLoughery
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Cyclin-dependent kinase 4/6 inhibitor-associated thromboembolism: a critical evaluation of the current evidenceNathan W Watson, Joseph J Shatzel, Hanny Al-Samkari
Thrombosis and Haemostasis|April 15, 2016
Non-vitamin K antagonist oral anticoagulants for heparin-induced thrombocytopenia. A systematic review of 54 reported casesJoseph J Shatzel, Meg Crapster-Pregont, Thomas G Deloughery
Pageof 13